OxTalks is Changing
OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
The efficacy and safety of pramipexole augmentation in treatment resistant depression: Results of the PAX-D trial.
There has been interest in the use of dopaminergic agonists in patients with treatment resistant depression (TRD), although they have only been assessed in small-scale, short-term studies. We conducted a substantial RCT examining the effect and safety/tolerability of the dopamine agonist pramipexole in patients with TRD, the PAX-D trial. In this talk I will present the efficacy and safety results from the trial.
This seminar is hosted in person and online, to join online, please use the Zoom details below:
zoom.us/j/93598736019?pwd=tHJ65nmXIrmYTUhi7YRbbdlnyi5Ie6.1
Meeting ID: 935 9873 6019
Passcode: 897963
Date:
4 March 2025, 9:30
Venue:
Department of Psychiatry, Headington OX3 7JX
Venue Details:
Seminar Room
Speaker:
Professor Michael Browning (Department of Psychiatry, University of Oxford)
Organising department:
Department of Psychiatry
Organiser:
Rania Elgarf (Department of Psychiatry, University of Oxford)
Organiser contact email address:
rania.elgarf@psych.ox.ac.uk
Host:
Professor Phil Cowen (Professor of Psychopharmacology, University of Oxford )
Part of:
Psychiatry Seminar Series
Booking required?:
Not required
Audience:
Public
Editor:
Rania Elgarf
